NCT05047146已完成不适用
The Clinicopathological and Prognostic Factors of Hepatocellular Carcinoma; 10 Years' Tertiary Center Experience in Egypt
Sadat City University1 个研究点 分布在 1 个国家目标入组 530 人开始时间: 2021年1月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 530
- 试验地点
- 1
- 主要终点
- Clinicopathological factors of Hepatocellular Carcinoma
研究概览
简要总结
This study aimed at study the clinical and pathological criteria of Hepatocellular carcinoma to keep with new challenging in diagnosis and morpho-molecular classifications
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •All pathologically proven Hepatocellular Carcinoma
排除标准
- •Other malignant tumors than Hepatocellular Carcinoma
- •Benign tumor
结局指标
主要结局
Clinicopathological factors of Hepatocellular Carcinoma
时间窗: 10 years
The reserve of background liver
次要结局
未报告次要终点
研究者
Mahmoud Samy Abdallah
Lecturer of Clinical Pharmacy
Sadat City University
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Clinicopathological factors in hepatocellular carcinoma with microscopic portal vein invasion.Hepatocellular carcinomaJPRN-UMIN000017852Department of Gastroenterological surgery I, Hokkaido University
尚未招募
不适用
Clinical study of liver cancerCTRI/2023/02/049609Kasturba Medical College, Manipal
已完成
不适用
Postoperative Adjuvant Immunotherapy for Hepatocellular Carcinoma: Risk Factor Analysis and Prognostic ModellingAdjuvant ImmunotherapyCheckpoint InhibitorHepatocellular CarcinomaNCT06298123Chen Xiaoping304
Unknown
不适用
Risk of Hepatocellular Carcinoma in Patient With Liver CirrhosisCarcinoma, HepatocellularNCT03083002University of Modena and Reggio Emilia250
招募中
不适用
Perioperative Risk of Immunotherapy Based Neoadjuvant and Conversion Therapy for Hepatocellular CarcinomaCarcinoma, HepatocellularImmunotherapyNCT06571396Qilu Hospital of Shandong University200